Exagen Announces Campaign for Lupus Awareness Month

Lupus Awareness Month occurs every May and is an opportunity for lupus-focused organizations to take intentional steps in creating awareness around lupus a...

May 02, 2023 | Tuesday | News
Could Tumoroids Solve the Problem of High Attrition in Cancer Trials?

There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...

May 01, 2023 | Monday | News
Study Suggests Catalyst for Human Brain Evolution

More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion...

May 01, 2023 | Monday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
UCLA Health and CHOC collaborate to enhance access to pediatric congenital cardiac care

"Our shared vision is one program offered at two sites to provide patients with the right care in a location close to home," said Dr. Glen Van Arsdell, who...

April 28, 2023 | Friday | News
Roche's Columvi Gets CHMP Nod for Fixed-Duration Use in Diffuse Large B-cell Lymphoma

The recommendation is based on results from the phase I/II NP30179 study, where Columvi given as a fixed course induced early and long-lasting complete r...

April 27, 2023 | Thursday | Regulatory
Tofersen's FDA accelerated approval highlights blood neurofilament light chain's significance as surrogate endpoint in neurology trials

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today...

April 26, 2023 | Wednesday | News
Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News
Simcere Pharma on Fast Track to Becoming Innovation-Driven Global Company with Four New Drug Launches in Three Years

-The revenue from innovative drugs accounted for more than 65% of total revenue  -Simcere's total revenue and the revenue from in...

April 24, 2023 | Monday | News
First Coast Cardiovascular Institute Announces Partnership With Cardiovascular Logistics

CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI will join a network of leading practices across the coun...

April 24, 2023 | Monday | News
Sanofi Launches AVAXIM® Junior in UK for Hepatitis A Virus Immunisation in Children

Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of AVAXIM® Junior in the UK, an inactive hepatitis A vaccine indicated for use in...

April 24, 2023 | Monday | News
Zylox-Tonbridge Forms Strategic Partnership with Hicicare for Innovative Chinese Vascular Guidewire Solutions

With the collaboration, Zylox Medical, the Company's peripheral vascular business unit, plans to launch the "Zylox-Hicicare Guidewire Family" products to a...

April 24, 2023 | Monday | News
FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology and 5-Minute Auto Corrections.

 Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its Mini...

April 22, 2023 | Saturday | News
AbbVie Presents Late-Breaking Atogepant Phase 3 Results for Episodic Migraine Treatment at 2023 AAN Meeting.

The Phase 3 ELEVATE study demonstrated atogepant is effective and well-tolerated for the preventive treatment of episodic migraine in people who previous...

April 21, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close